Resultados de la búsqueda 171-180 of 11818 for Antifungal Resistance

  1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... resistance to 131I-MIBG and crizotinib. Study Of Treating Patients With Vestibular Schwannoma With Aspirin. Rochester, Minn. The purpose of this study is to ...

  2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... resistance to 131I-MIBG and crizotinib. Numeración de páginas Estudios clínicos. AnteriorPágina anterior · Ir a página 2121 · Ir a página 2222 · Ir a página 23 ...

  3. Terapia hormonal para el cáncer de próstata - Médicos y departamentos - Mayo Clinic

    Dawson NA, et al. Overview of the treatment of castration-resistant prostate cancer (CRPC). https://www.uptodate.com/contents/search. Accessed June 12, ...

  4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... resistance to 131I-MIBG and crizotinib. Methylation And Chromatin Abnormalities In Myelodysplastic Syndromes And Chronic Myelomonocytic Leukemia. Rochester ...

  5. Cirugía - Ensayos clínicos - Mayo Clinic

    ... resistant prostate cancer (mCRPC) who have received prior anti-cancer treatment and have a positive 68Ga-PSMA-11 PET scan. The purpose of this study is to ...

  6. Cirugía - Ensayos clínicos - Mayo Clinic

    ... resistant prostate cancer (mCRPC) who have received prior anti-cancer treatment and have a positive 68Ga-PSMA-11 PET scan. The purpose of this study is to ...

  7. Cirugía - Ensayos clínicos - Mayo Clinic

    ... resistant prostate cancer (mCRPC) who have received prior anti-cancer treatment and have a positive 68Ga-PSMA-11 PET scan. The purpose of this study is to ...

  8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... resistance to 131I-MIBG and crizotinib. Study Of Treating Patients With Vestibular Schwannoma With Aspirin. Rochester, Minn. The purpose of this study is to ...

  9. Cirugía - Ensayos clínicos - Mayo Clinic

    ... resistant prostate cancer (mCRPC) who have received prior anti-cancer treatment and have a positive 68Ga-PSMA-11 PET scan. The purpose of this study is to ...

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    PARP inhibitors are a type of targeted therapy. Adding abemaciclib to olaparib may work better to treat recurrent platinum-resistant ovarian cancer.